Arcturus Therapeutics Holdings Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 16,006 | 0.1% | 2,611,099 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 34,514 | 0.2% | 1,872,721 | 9/30/2025 |
| 2025 Q2 | 7/30/2025 | 22,313 | 0.2% | 1,715,040 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 21,270 | 0.2% | 2,008,480 | 3/31/2025 |
| 2024 Q4 | 2/4/2025 | 32,817 | 0.3% | 1,933,851 | 12/31/2024 |
| 2024 Q3 | 10/31/2024 | 48,765 | 0.4% | 2,101,038 | 9/30/2024 |
| 2024 Q2 | 7/26/2024 | 47,847 | 0.4% | 1,964,964 | 6/30/2024 |
| 2024 Q1 | 4/18/2024 | 57,059 | 0.4% | 1,689,649 | 3/31/2024 |
| 2023 Q4 | 1/17/2024 | 64,564 | 0.4% | 2,047,687 | 12/31/2023 |
| 2023 Q3 | 10/18/2023 | 48,585 | 0.4% | 1,901,546 | 9/30/2023 |
| 2023 Q2 | 7/10/2023 | 54,693 | 0.4% | 1,906,996 | 6/30/2023 |
| 2023 Q1 | 4/17/2023 | 47,591 | 0.3% | 1,985,421 | 3/31/2023 |
| 2022 Q4 | 1/24/2023 | 34,131 | 0.3% | 2,012,429 | 12/31/2022 |
| 2022 Q3 | 10/17/2022 | 32,333 | 0.2% | 2,181,703 | 9/30/2022 |
| 2022 Q2 | 7/11/2022 | 45,799 | 0.3% | 2,303,751 | 6/30/2022 |
| 2022 Q1 | 4/19/2022 | 64,268 | 0.3% | 2,383,840 | 3/31/2022 |
| 2021 Q4 | 1/28/2022 | 91,512 | 0.3% | 2,472,630 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 120,860 | 0.3% | 2,529,509 | 9/30/2021 |
| 2021 Q2 | 8/5/2021 | 97,618 | 0.2% | 2,884,682 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 137,607 | 0.3% | 3,331,889 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 171,742 | 0.5% | 3,959,019 | 12/31/2020 |
| 2020 Q3 | 10/30/2020 | 107,072 | 0.6% | 2,495,842 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 89,686 | 1.0% | 1,918,835 | 6/30/2020 |
| 2020 Q1 | 5/14/2020 | 21,261 | 0.5% | 1,564,457 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 15,041 | 0.4% | 1,383,756 | 12/31/2019 |